BIOTRICITY INC.
BTCY · OTCMCIK 1630113fmd_16BG2QKKXM0FW1WWZCFKZSKX4JManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Sep 01, 2013 to Jun 30, 2026, 53 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | 0 | 1 | 3 | 8 | 10 | 12 | 14 | 16 |
| Cost of revenue | – | – | 0 | 1 | 2 | 3 | 4 | 4 | 3 | 3 |
| Gross profit | – | – | 0 | 0 | 1 | 5 | 5 | 8 | 11 | 13 |
| Research and development | 1 | 2 | 1 | 1 | 2 | 3 | 3 | 3 | 2 | 3 |
| Selling, general and administrative | – | – | – | – | – | 19 | 18 | 15 | 11 | 8 |
| Total operating expenses | 6 | 8 | 9 | 11 | 15 | 21 | 21 | 17 | 13 | 11 |
| Operating income | – | – | (9) | (11) | (13) | (17) | (15) | (9) | (2) | 2 |
| Interest expense | – | – | – | – | 0 | 1 | 2 | 3 | 3 | 3 |
| Other non-operating income (expense) | – | – | – | (0) | 0 | 0 | (0) | (0) | (0) | 0 |
| Income before taxes | – | (9) | (9) | (11) | (15) | (29) | (19) | (14) | (8) | (2) |
| Net income | (8) | (9) | (9) | (11) | (15) | (29) | (19) | (14) | (8) | (2) |
| Net income to common shareholders | – | – | (9) | (11) | (16) | (30) | (20) | (15) | (12) | (3) |